100 Women in Finance Selects the Karen Leung Foundation as its 2017 Hong Kong Beneficiary – 5th Annual Hong Kong Gala Set for November 16

Apr 21, 2017

100 Women in Finance (“100 Women”) today announces that The Karen Leung Foundation, Ltd. (“KLF”) has been designated as its 2017 philanthropic beneficiary in Hong Kong.

100 Women is a global network of professionals in the finance and alternative investment industries working together to empower women at every stage of their careers. Through peer engagement, philanthropic and educational initiatives, 100 Women’s more than 15,000 members are making connections and creating opportunities that help to advance careers and strengthen their field. To date, 100 Women has raised more than US$40 million (gross) for charitable causes around the world.

Empowering women in finance also means supporting women and families across the world. 100 Women’s galas and fundraising events benefit organizations dedicated to improving lives through mentoring, women’s and family health, and education. 100 Women’s global theme rotates on an annual basis to ensure the greatest impact for local communities. This year’s global theme is Women’s and Family Health.

KLF was established in the memory of Karen Leung, a Hong Kong hedge fund trader, who lost her life following a diagnosis with metastatic cervical cancer. Today, KLF provides critical education, preventive vaccination, and care support to young women in Hong Kong who would otherwise not have access to these services. 100 Women funding will allow KLF to expand the capacity of an existing complimentary school-based HPV vaccination program for girls, as well as adding a free screening program for the girls’ mothers in Hong Kong’s low income districts. KLF also plans to launch an education and screening program for young women working in Hong Kong’s financial sector.

According to Amy Yeung, Chair of 100 Women’s Hong Kong Beneficiary Selection Committee and PwC partner, “KLF addresses the medical needs of young women in Hong Kong, making for a particularly strong philanthropic partnership with 100 Women. Its work will certainly resonate with our membership.”

Katharina Reimer, Executive Director of KLF, said: “We are beyond excited to be named 100 Women’s 2017 Hong Kong beneficiary. Funding from 100 Women will allow us to build on the success of our school-based vaccination program for girls and also offer free HPV screening program for the girls’ mothers.”

100 Women’s primary fundraiser in Hong Kong will be its annual Gala dinner, scheduled for November 16, 2017 at the China Club. This year’s Hong Kong Gala Co-Chair, Ann Ng, Partner of Maples and Calder Hong Kong, noted, “The 100 Women Hong Kong Gala has become an important, intimate industry event that is looked forward to by a broadening spectrum of the financial community including private equity and hedge funds, allocators, and service providers.”

Her Co-Chair, Katarina Royds of Ascalon Capital Managers, added that the 2017 Gala falls just at the close of the AVCJ Private Equity and Venture Forum in Hong Kong. “With strong interest from many of last year’s corporate sponsors and senior practitioners to continue supporting our fundraising events, we expect the remaining tables to sell out rapidly this year. We aim to raise the bar on the money we can help raise for an important cause.”

Ticket and sponsorship inquiries regarding the 100 Women Hong Kong Gala should be directed to the Hong Kong Gala Committee.

About Karen Leung Foundation
The Karen Leung Foundation was established in June 2013 to promote gynecological cancer education, awareness, prevention and treatment in Hong Kong. KLF is working to save lives in Hong Kong by raising awareness of gynecological cancer, educating women to increase rates of early detection, providing access to clinical preventive measures, and ensuring that women in treatment have access to optimal medical care. The Karen Leung Foundation honors the memory of Karen Leung, a hedge fund trader, who died at age 35 following a diagnosis of metastatic cervical cancer.

Media Contact